BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 27938677)

  • 1. First evaluation of an influenza viral vector based Brucella abortus vaccine in sheep and goats: Assessment of safety, immunogenicity and protective efficacy against Brucella melitensis infection.
    Tabynov K; Yespembetov B; Matikhan N; Ryskeldinova S; Zinina N; Kydyrbayev Z; Assanzhanova N; Tabynov K; Renukaradhya GJ; Mukhitdinova G; Sansyzbay A
    Vet Microbiol; 2016 Dec; 197():15-20. PubMed ID: 27938677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
    Tabynov K; Ryskeldinova S; Sansyzbay A
    Vaccine; 2015 Jul; 33(31):3619-23. PubMed ID: 26093199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector-Based
    Mailybayeva A; Ryskeldinova S; Zinina N; Zhou EM; Renukaradhya GJ; Tabynov K
    Front Vet Sci; 2020; 7():58. PubMed ID: 32175335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of brucellosis in Kuwait by vaccination of cattle, sheep and goats with Brucella abortus strain 19 or Brucella melitensis strain Rev. 1.
    al-Khalaf SA; Mohamad BT; Nicoletti P
    Trop Anim Health Prod; 1992 Feb; 24(1):45-9. PubMed ID: 1306918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
    Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A
    Virol J; 2014 Apr; 11():69. PubMed ID: 24716528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
    Higgins JL; Bowen RA; Gonzalez-Juarrero M
    Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Yespembetov B; Zinina N; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Gotskina T; Sansyzbay A
    Vaccine; 2014 Apr; 32(18):2034-41. PubMed ID: 24598723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
    Blasco JM
    Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.
    el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A
    Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
    Díaz-Aparicio E; Hernández L; Suárez-Güemes F
    Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing
    Bugybayeva D; Ryskeldinova S; Zinina N; Sarmykova M; Assanzhanova N; Kydyrbayev Z; Tabynov K
    Biomed Res Int; 2020; 2020():1438928. PubMed ID: 33274194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of a
    Kim WK; Moon JY; Cho JS; Hur J
    Can J Vet Res; 2019 Oct; 83(4):261-266. PubMed ID: 31571725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep.
    Pérez-Sancho M; Adone R; García-Seco T; Tarantino M; Diez-Guerrier A; Drumo R; Francia M; Domínguez L; Pasquali P; Álvarez J
    Vaccine; 2014 Apr; 32(16):1877-81. PubMed ID: 24508034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
    Uslu A; Erganis O
    Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of an inactivated
    Kim WK; Moon JY; Cho JS; Ochirkhuyag E; Akanda MR; Park BY; Hur J
    Can J Vet Res; 2019 Jan; 83(1):68-74. PubMed ID: 30670904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.